Release--With the upcoming release of Wingspan eTMF 2.0, Wingspan Technology is holding an exclusive preview webinar
With the upcoming release of Wingspan eTMF 2.0, Wingspan Technology is holding an exclusive preview webinar
With the upcoming release of Wingspan eTMF 2.0, Wingspan Technology is holding an exclusive preview webinar
January 13, 2014; BLUE BELL, PA— Wingspan Technology, Inc. plans to release its Wingspan eTMF overhaul, eTMF 2.0 in Q1 2014. On January 22, 2014, Wingspan will debut its revolutionary eTMF product for the first time for public demonstration.
While many document management system interfaces have remained largely unchanged since the 1990s, Wingspan eTMF 2.0 has been re-designed to provide:
· A user experience modeled on commercial web sites such as Amazon and eBay – dramatically reducing user training time and frustration
· Unprecedented insight into the status and health of ongoing trials
· Simple processes for uploading and checking documents that greatly decrease both the time needed for these processes and the possibility of error
Behind the scenes, Wingspan eTMF 2.0 uses the robust and scalable infrastructure and processes that have a proven track record of supporting users in more than 60 countries worldwide in processing up to 10,000 documents per day. Registration for this demo is currently open; you can register online
About Wingspan Technology, Inc.
Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025